Loading clinical trials...
Loading clinical trials...
This is a phase 1, open-label study in healthy adults. This study is aimed at evaluating the safety, tolerability, and pharmacokinetics of ASC43F, a fixed-dose combination (FDC) and single dose tablet...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gannex Pharma Co., Ltd.
NCT00090662 · Healthy Volunteer
NCT07021079 · Vibration Therapy, Healthy Volunteer Study, and more
NCT05545306 · Obesity, Normal Physiology, and more
NCT07247773 · Healthy Volunteers
NCT05078905 · COVID-19, Vaccination, and more
8307 Gault Lane
San Antonio, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions